This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Pulmonary fibrosis in Interstitial Lung Diseases v2.0

  • Research type

    Research Study

  • Full title

    Pathogenesis and Clinical Manifestations of Pulmonary Fibrosis in (A) Connective Tissue Diseases (CTD), (B) Granulomatous Conditions (GC), and (C) Idiopathic Interstitial Pneumonias (IIP)

  • IRAS ID

    125496

  • Contact name

    Athol U Wells

  • Contact email

    athol.wells@rbht.nhs.uk

  • Sponsor organisation

    Royal Brompton Hospital

  • Research summary

    The principle research question is how genetic, immune and environmental factors interact to influence the development of lung fibrosis in (A) connective tissue diseases (CTD), (B) Granulomatous Conditions (GC), and (C) Idiopathic Interstitial Pneumonias (IIP). What are the critical genetic, biological and environmental components that can be used for the early identification of predisposition to lung fibrosis? The identification of these factors will also enhance our understanding of disease processes and may in future lead to the development of new therapies.

  • REC name

    London - Dulwich Research Ethics Committee

  • REC reference

    13/LO/0857

  • Date of REC Opinion

    5 Sep 2013

  • REC opinion

    Further Information Favourable Opinion